Royal Bank of Canada’s PAVmed PAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Hold
0
7272
2024
Q2
Hold
0
7408
2024
Q1
Sell
-1
Closed -$76 7441
2023
Q4
$0 Sell
1
-1
-50% -$118 ﹤0.01% 7458
2023
Q3
$0 Hold
2
﹤0.01% 7435
2023
Q2
$0 Buy
2
+1
+100% +$200 ﹤0.01% 7544
2023
Q1
$0 Buy
+1
New +$210 ﹤0.01% 7368
2022
Q4
Sell
-1
Closed 7583
2022
Q3
$0 Buy
+1
New +$567 ﹤0.01% 7739
2022
Q2
Sell
-10
Closed -$6K 7620
2022
Q1
$6K Sell
10
-101
-91% -$75.1K ﹤0.01% 7191
2021
Q4
$123K Buy
111
+84
+311% +$183K ﹤0.01% 5777
2021
Q3
$102K Buy
27
+16
+145% +$50.4K ﹤0.01% 5680
2021
Q2
$32K Sell
11
-1
-8% -$2.36K ﹤0.01% 6307
2021
Q1
$25K Buy
12
+5
+71% +$7.52K ﹤0.01% 6303
2020
Q4
$6K Buy
7
+6
+600% +$5.13K ﹤0.01% 6586
2020
Q3
$0 Buy
+1
New +$890 ﹤0.01% 6847
2020
Q2
Sell
-2
Closed -$2K 6833
2020
Q1
$1K Buy
2
+1
+100% +$818 ﹤0.01% 6472
2019
Q4
$0 Hold
1
﹤0.01% 7044
2019
Q3
$0 Buy
+1
New +$457 ﹤0.01% 6998

Other funds holding PAVM

Royal Bank of Canada's PAVM Position: Q3 2024 in Review

Royal Bank of Canada held its PAVmed (PAVM) position steady in Q3 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7272.

Royal Bank of Canada first reported a position in PAVM in Q3 2019 and has held it in 15 quarters since. The position peaked at $123K in Q4 2021. 19 funds tracked by Wall St. Rank hold PAVM as of Q3 2024.

  • Royal Bank of Canada held 0 shares of PAVmed worth $0 as of Q3 2024.
  • Royal Bank of Canada left its PAVmed share count unchanged in Q3 2024.
  • PAVmed made up ﹤0.01% of Royal Bank of Canada's portfolio in Q3 2024, its #7272 holding.
  • Royal Bank of Canada first reported a position in PAVmed in Q3 2019 and has held it in 15 quarters since.
  • Royal Bank of Canada's PAVmed position peaked at $123K in Q4 2021.
  • 19 funds tracked by Wall St. Rank held PAVmed as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.